Alteryx Inc - Ordinary Shares (AYX) 10-Q 6 Nov 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Oct. 30, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-38034
Entity Registrant Name	Alteryx, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0673106
Entity Address, Address Line One	17200 Laguna Canyon Road,
Entity Address, City or Town	Irvine,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92618
City Area Code	888
Local Phone Number	836-4274
Title of 12(b) Security	Class A Common Stock, $0.0001 par value per share
Trading Symbol	AYX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001689923
Current Fiscal Year End Date	--12-31
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		63,894,359
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,886,450

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Total revenue	$ 232	$ 215	$ 619	$ 554
Cost of revenue:
Total cost of revenue	34	32	97	86
Gross profit	198	183	522	468
Operating expenses:
Research and development	53	55	169	162
Sales and marketing	133	136	446	385
General and administrative	49	57	146	173
Impairment of long-lived assets	0	0	2	8
Total operating expenses	235	248	763	728
Loss from operations	(37)	(65)	(241)	(260)
Interest expense	(12)	(2)	(30)	(7)
Other income (expense), net	1	(7)	19	(16)
Loss before provision for income taxes	(48)	(74)	(252)	(283)
Provision for income taxes	2	1	7	4
Net loss	$ (50)	$ (75)	$ (259)	$ (287)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.70)	$ (1.09)	$ (3.67)	$ (4.20)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.70)	$ (1.09)	$ (3.67)	$ (4.20)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares)	71,305	68,673	70,615	68,273
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares)	71,305	68,673	70,615	68,273
Other comprehensive income, net of tax:
Net unrealized holding gain (loss) on investments, net of tax	$ 1	$ 0	$ 3	$ (3)
Foreign currency translation adjustments, net of tax	6	4	(2)	9
Other comprehensive income, net of tax	7	4	1	6
Total comprehensive loss	(43)	(71)	(258)	(281)
Subscription-based software license
Revenue:
Total revenue	117	111	284	255
Cost of revenue:
Total cost of revenue	1	3	5	8
PCS and services
Revenue:
Total revenue	115	104	335	299
Cost of revenue:
Total cost of revenue	$ 33	$ 29	$ 92	$ 78

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 463	$ 105
Short-term investments	172	237
Accounts receivable, net	130	260
Prepaid expenses and other current assets	162	145
Total current assets	927	747
Property and equipment, net	68	69
Operating lease right-of-use assets	42	51
Long-term investments	47	90
Goodwill	398	398
Intangible assets, net	51	61
Other assets	135	141
Total assets	1,668	1,557
Current liabilities:
Accounts payable	12	14
Accrued payroll and payroll related liabilities	55	81
Accrued expenses and other current liabilities	53	56
Deferred revenue	179	276
Convertible senior notes, net	399	85
Total current liabilities	698	512
Long-term debt, net	838	793
Operating lease liabilities	49	61
Other liabilities	16	17
Total liabilities	1,601	1,383
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value: 10,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	0	0
Common stock, $0.0001 par value: 500,000 Class A shares authorized, 63,837 and 61,616 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively; 500,000 Class B shares authorized, 7,886 and 7,886 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	0	0
Additional paid-in capital	774	623
Accumulated deficit	(702)	(443)
Accumulated other comprehensive loss	(5)	(6)
Total stockholders’ equity	67	174
Total liabilities and stockholders’ equity	$ 1,668	$ 1,557

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	63,837,000	61,616,000
Common stock, shares outstanding (in shares)	63,837,000	61,616,000
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	7,886,000	7,886,000
Common stock, shares outstanding (in shares)	7,886,000	7,886,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			67,534
Beginning balance at Dec. 31, 2021	$ 403	$ (111)	$ 0	$ 599	$ (177)	$ (190)	$ 66	$ (6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			434
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(14)			(14)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			160
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	5			5
Stock-based compensation	53			53
Cumulative translation adjustment	2							2
Unrealized gain (loss) on investments, net of tax	(2)							(2)
Net loss	(105)					(105)
Ending balance (in shares) at Mar. 31, 2022			68,128
Ending balance at Mar. 31, 2022	231		$ 0	466		(229)		(6)
Beginning balance (in shares) at Dec. 31, 2021			67,534
Beginning balance at Dec. 31, 2021	403	$ (111)	$ 0	599	$ (177)	(190)	$ 66	(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative translation adjustment	9
Unrealized gain (loss) on investments, net of tax	(3)
Net loss	(287)
Ending balance (in shares) at Sep. 30, 2022			68,910
Ending balance at Sep. 30, 2022	157		$ 0	568		(411)		0
Beginning balance (in shares) at Mar. 31, 2022			68,128
Beginning balance at Mar. 31, 2022	231		$ 0	466		(229)		(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			329
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(12)			(12)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			4
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	0
Stock-based compensation	58			58
Cumulative translation adjustment	3							3
Unrealized gain (loss) on investments, net of tax	(1)							(1)
Net loss	(107)					(107)
Ending balance (in shares) at Jun. 30, 2022			68,461
Ending balance at Jun. 30, 2022	172		$ 0	512		(336)		(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			325
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(11)			(11)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			124
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	5			5
Stock-based compensation	62			62
Cumulative translation adjustment	4							4
Unrealized gain (loss) on investments, net of tax	0
Net loss	(75)					(75)
Ending balance (in shares) at Sep. 30, 2022			68,910
Ending balance at Sep. 30, 2022	157		$ 0	568		(411)		0
Beginning balance (in shares) at Dec. 31, 2022			69,502
Beginning balance at Dec. 31, 2022	174		$ 0	623		(443)		(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			767
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(27)			(27)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			159
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	9			9
Stock-based compensation	60			60
Extinguishment of capped calls (in shares)			(10)
Conversion on 2023 Notes, net of tax (in shares)			9
Conversion of 2023 Notes, net of tax	0							0
Cumulative translation adjustment	(4)							(4)
Unrealized gain (loss) on investments, net of tax	2							2
Net loss	(89)					(89)
Ending balance (in shares) at Mar. 31, 2023			70,427
Ending balance at Mar. 31, 2023	125		$ 0	665		(532)		(8)
Beginning balance (in shares) at Dec. 31, 2022			69,502
Beginning balance at Dec. 31, 2022	174		$ 0	623		(443)		(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative translation adjustment	(2)
Unrealized gain (loss) on investments, net of tax	3
Net loss	(259)
Ending balance (in shares) at Sep. 30, 2023			71,723
Ending balance at Sep. 30, 2023	67		$ 0	774		(702)		(5)
Beginning balance (in shares) at Mar. 31, 2023			70,427
Beginning balance at Mar. 31, 2023	125		$ 0	665		(532)		(8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			573
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(13)			(13)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			29
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	0
Stock-based compensation	64			64
Cumulative translation adjustment	(4)							(4)
Net loss	(120)					(120)
Ending balance (in shares) at Jun. 30, 2023			71,029
Ending balance at Jun. 30, 2023	52		$ 0	716		(652)		(12)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units (in shares)			500
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(8)			(8)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			194
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	4			4
Stock-based compensation	62			62
Cumulative translation adjustment	6							6
Unrealized gain (loss) on investments, net of tax	1							1
Net loss	(50)					(50)
Ending balance (in shares) at Sep. 30, 2023			71,723
Ending balance at Sep. 30, 2023	$ 67		$ 0	$ 774		$ (702)		$ (5)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (259)	$ (287)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	27	27
Non-cash operating lease cost	9	15
Stock-based compensation	183	164
Amortization (accretion) of discounts and premiums on investments, net	(4)	1
Amortization of debt discount and issuance costs	3	2
Deferred income taxes	4	2
Impairment of long-lived assets	2	8
Other non-cash operating activities, net	3	21
Changes in operating assets and liabilities, net of effect of business acquisitions:
Accounts receivable	127	83
Deferred commissions	(12)	(9)
Prepaid expenses, other current assets, and other assets	6	(94)
Accounts payable	(1)	15
Accrued payroll and payroll related liabilities	(27)	(23)
Accrued expenses, other current liabilities, operating lease liabilities, and other liabilities	(18)	(13)
Deferred revenue	(94)	(25)
Net cash used in operating activities	(51)	(113)
Cash flows from investing activities:
Capitalized software development costs	(15)	(8)
Purchases of property and equipment	(2)	(20)
Cash paid in acquisitions, net of cash acquired	0	(387)
Purchases of investments	(143)	(115)
Sales and maturities of investments	245	608
Net cash provided by investing activities	85	78
Cash flows from financing activities:
Proceeds from issuance of senior notes, net of issuance costs	441	0
Principal payments on 2023 convertible senior notes	(85)	0
Proceeds from exercise of stock options and issuance of shares from employee stock purchase plan	13	10
Minimum tax withholding paid on behalf of employees for restricted stock units	(48)	(37)
Other financing activity	1	0
Net cash provided by (used in) financing activities	322	(27)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(3)
Net increase (decrease) in cash, cash equivalents and restricted cash	356	(65)
Cash, cash equivalents and restricted cash—beginning of period	110	155
Cash, cash equivalents and restricted cash—end of period	466	90
Supplemental disclosure of cash flow information:
Cash paid for interest	27	6
Cash paid for income taxes	3	2
Cash paid for amounts included in the measurement of operating lease liabilities	17	17
Supplemental disclosure of noncash investing and financing activities:
Property and equipment recorded in accounts payable and accrued expenses and other current liabilities	0	4
Right-of-use assets obtained in exchange for new operating lease liabilities	0	3
Stock-based compensation included in capitalized software development costs	4	3
Commissions paid with Class A common stock	$ 3	$ 8

Business

Business	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	Business Our Company Alteryx, Inc. and its subsidiaries, or we, our, or us, are headquartered in Irvine, California. The Alteryx Analytics Automation Platform empowers “analytics for all” by delivering easy, end-to-end automation of data engineering, analytics, reporting, machine learning, and data science processes, enabling enterprises to democratize data analytics across their organizations for a broad range of use cases. Whether working in the cloud or on-premise, data workers, regardless of technical acumen, are empowered to be curious and solve problems. With the Alteryx Analytics Automation Platform, users can automate the full range of analytics and data science processes, embed intelligent decision-making and actions, and empower their organization to enable top and bottom-line impact, efficiency gains, and rapid upskilling. Basis of Presentation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Alteryx, Inc. and its subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim periods. Certain information and disclosures normally included in consolidated financial statements presented in accordance with U.S. GAAP have been condensed or omitted. Certain reclassifications have been made to the fiscal year 2022 condensed consolidated financial statements to conform to the fiscal year 2023 presentation. The reclassifications had no impact on comprehensive loss, total assets, total liabilities, or stockholders’ equity. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, or the Annual Report, filed with the Securities and Exchange Commission, or SEC, on February 10, 2023. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments that are necessary to state fairly the financial position, results of operations, comprehensive loss, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending December 31, 2023. During the three months ended June 30, 2023, management elected to change the presentation of our financial statements and accompanying footnote disclosures from thousands to millions. The change in presentation had no material impact on previously reported financial information, but certain amounts reported for prior periods may differ by insignificant amounts due to the nature of rounding relative to the change in presentation. In addition, historical percentages and per share amounts presented may not add to their respective totals or recalculate due to rounding.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Other than as described below, there have been no changes to our accounting policies disclosed in our audited consolidated financial statements and the related notes for the year ended December 31, 2022. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, income tax valuations, stock-based compensation, and goodwill and intangible assets valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements, or recently adopted accounting guidance during the nine months ended September 30, 2023 that are of significance or potential significance to us.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue related to our subscription-based software licenses is recognized at a point in time when the platform is first made available to the customer, or the beginning of the subscription term, if later. Revenue related to post-contract support, or PCS, subscription-based professional services, cloud-based offerings, and subscriptions to third-party syndicated data is recognized ratably over the subscription term, with the exception of professional services related to training and enablement services. Revenue related to professional services that are training and enablement services is recognized at a point in time as the services are performed. For the periods presented, revenue from professional services was not material. Disaggregation of Revenue The disaggregation of revenue by region was as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by region: United States $ 169 $ 141 $ 441 $ 381 International 63 74 178 173 Total $ 232 $ 215 $ 619 $ 554 Revenue attributable to the United Kingdom and Canada comprised 10.6% and 11.3%, respectively, of the total revenue for the three months ended September 30, 2022. Other than the United Kingdom and Canada for the three months ended September 30, 2022, no other country outside the United States comprised more than 10% of revenue for any of the periods presented. Our operations outside the United States include sales offices in Australia, France, Germany, Japan, Singapore, United Arab Emirates, and the United Kingdom, and research and development centers in Australia, the Czech Republic, India, and Ukraine. Revenue by location is determined by the billing address of the customer. Contract Assets and Contract Liabilities Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. Contract assets primarily relate to unbilled amounts for contracts with customers for which the amount of revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to accounts receivable when the right to invoice becomes unconditional. Contract liabilities, or deferred revenue, are recorded for amounts that are collected in advance of the satisfaction of performance obligations. As of September 30, 2023 and December 31, 2022, we had deferred revenue of $179 million and $276 million, respectively, included in current deferred revenue and $4 million and $4 million, respectively, included in other liabilities on our condensed consolidated balance sheet. During the three months ended September 30, 2023 and 2022, we recognized $94 million and $91 million, respectively, of revenue related to amounts that were included in deferred revenue as of June 30, 2023 and 2022, respectively. During the nine months ended September 30, 2023 and 2022, we recognized $233 million and $180 million, respectively, of revenue related to amounts that were included in deferred revenue as of December 31, 2022 and 2021, respectively. Assets Recognized from the Costs to Obtain our Contracts with Customers We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. This primarily consists of sales commissions and partner referral fees that are earned upon execution of the related contracts. We amortize these deferred commissions, which include partner referral fees, proportionate with related revenues over the benefit period. A summary of the activity impacting our deferred commissions during the three and nine months ended September 30, 2023 and 2022 is presented below (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Beginning balance (1) $ 103 $ 71 $ 96 $ 70 Additional deferred commissions 25 25 73 58 Amortization of deferred commissions (21) (19) (63) (49) Effects of foreign currency translation (1) (1) — (3) Ending balance $ 106 $ 76 $ 106 $ 76 (1) Of the total amount of commissions deferred as of January 1, 2023 and January 1, 2022, $2 million and $6 million were paid in shares of our Class A common stock in the nine months ended September 30, 2023 and September 30, 2022, respectively. No payments were made in shares in the three months ended September 30, 2023 and September 30, 2022. As of September 30, 2023 and 2022, $46 million and $33 million, respectively, of our deferred commissions were expected to be amortized within the next 12 months and therefore were included in prepaid expenses and other current assets. The remaining amount of our deferred commissions is included in other assets. There were no impairments of assets related to deferred commissions during each of the three and nine months ended September 30, 2023 and 2022. There were no assets recognized related to the costs to fulfill contracts during each of the three and nine months ended September 30, 2023 and 2022 as these costs were not material. Remaining Performance Obligations Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue on our condensed consolidated balance sheets and unbilled amounts that will be recognized as revenue in future periods. As of September 30, 2023, we had an aggregate transaction price of $517 million allocated to unsatisfied performance obligations related primarily to PCS, cloud-based offerings, and subscriptions to third-party syndicated data. We expect to recognize $483 million as revenue over the next 24 months, with the remaining amount expected to be recognized thereafter.

Business Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Trifacta Inc. On February 7, 2022, we acquired 100% of the outstanding equity of Trifacta Inc., or Trifacta, pursuant to an Agreement and Plan of Merger, dated January 6, 2022, or the Trifacta Merger Agreement. The acquisition was made to augment our product and go-to-market teams and acquire developed technology to advance our cloud-based functionalities. The aggregate consideration payable in exchange for all of the outstanding equity interests in Trifacta, inclusive of customary adjustments set forth in the Trifacta Merger Agreement, was $398 million. The transaction costs associated with the acquisition were approximately $11 million, of which $8 million was incurred during the nine months ended September 30, 2022 and was recorded in general and administrative expense. The purchase consideration for the acquisition primarily consisted of $341 million of goodwill and $49 million in completed technology. We determined the fair value of the developed technology acquired using the multi-period excess earnings model, which is a variation of the income approach that estimates the value of the assets based on the present value of the incremental after-tax cash flow attributable only to the intangible assets. This model utilizes certain unobservable inputs classified as Level 3 measurements as defined by ASC 820, Fair Value Measurements and Disclosures , or ASC 820. Key inputs utilized in the models include a discount rate of 16.5% and estimated revenue and expense forecasts. The operations of Trifacta are included in our operating results from the date of acquisition. We have not separately disclosed the amount of revenue or earnings related to the Trifacta acquisition as the operations of Trifacta were integrated into the operations of our company from the date of acquisition, and thus it would be immaterial and impractical to do so. In addition, the unaudited pro forma results of operations assuming the Trifacta acquisition had taken place at the beginning of each period are not provided as the historical operating results of Trifacta were not material.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Instruments Measured at Fair Value on a Recurring Basis. The following tables present our cash and cash equivalents’ and investments’ costs, net unrealized gains (losses), and fair value by major security type recorded as cash and cash equivalents or short-term or long-term investments as of September 30, 2023 and December 31, 2022 (in millions): As of September 30, 2023 Cost Net Fair Value Cash and Short-term Long-term Cash $ 43 $ — $ 43 $ 43 $ — $ — Level 1: Money market funds 406 — 406 406 — — Subtotal 406 — 406 406 — — Level 2: Commercial paper 28 — 28 14 14 — Certificates of deposit 6 — 6 — 6 — U.S. Treasury and agency bonds 186 (1) 185 — 140 45 Corporate bonds 14 — 14 — 12 2 Subtotal 234 (1) 233 14 172 47 Level 3: — — — — — — Total $ 683 $ (1) $ 682 $ 463 $ 172 $ 47 As of December 31, 2022 Cost Net Fair Value Cash and Short-term Long-term Cash $ 63 $ — $ 63 $ 63 $ — $ — Level 1: Money market funds 20 — 20 20 — — Subtotal 20 — 20 20 — — Level 2: Commercial paper 60 — 60 21 39 — Certificates of deposit 6 — 6 — 6 — U.S. Treasury and agency bonds 237 (3) 234 1 156 77 Corporate bonds 46 (1) 45 — 36 9 Subtotal 349 (4) 345 22 237 86 Level 3: — — — — — — Total $ 432 $ (4) $ 428 $ 105 $ 237 $ 86 All long-term investments had maturities between one As of September 30, 2023, we had gross unrealized losses of $1 million with respect to $219 million aggregate fair value of our available-for-sale securities, and we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their amortized cost basis. These gross unrealized losses were classified in accumulated other comprehensive loss in our condensed consolidated balance sheets as of September 30, 2023. Instruments Not Recorded at Fair Value on a Recurring Basis. We estimate the fair value of our Notes, as defined in Note 9, Debt , carried at face value, less unamortized discount and issuance costs, quarterly for disclosure purposes. The estimated fair value of our Notes is determined by Level 2 inputs and is based on observable market data including prices for similar instruments. As of September 30, 2023, the fair value of the 2024 Notes, the 2026 Notes, and the 2028 Notes was $384 million, $359 million, and $449 million, respectively. As of December 31, 2022, the fair value of the 2023 Notes, the 2024 Notes, and the 2026 Notes was $105 million, $369 million, and $332 million, respectively. The carrying amounts of our accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their current fair value because of their nature and relatively short maturity dates or durations. Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis. See Note 4, Business Combinations , and Note 7, Goodwill and Intangible Assets , of these notes to our condensed consolidated financial statements for fair value measurements of certain assets and liabilities recorded at fair value on a non-recurring basis. These include the fair value of assets acquired and liabilities assumed in a business acquisition, and goodwill and other long-lived assets when they are held for sale or determin ed to be impaired. Other Investments. The table above does not include our debt and equity investments in which we do not have a controlling interest or significant influence. As of September 30, 2023, the balance of our investments was $12 million, which is included in other assets, compared to $4 million as of December 31, 2022, which is included in long-term investments. Since our initial investments, there have been no impairments or adjustments to the carrying amounts of our equity or debt investments.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Balance Sheet Components	Balance Sheet Components Prepaid expenses and other current assets consisted of the following (in millions): September 30, 2023 December 31, 2022 Contract asset $ 79 $ 60 Deferred commissions 46 41 Prepaid expenses 28 38 Other 9 6 Total $ 162 $ 145 Other assets consisted of the following (in millions): September 30, 2023 December 31, 2022 Contract asset $ 56 $ 71 Deferred commissions 60 55 Other 19 15 Total $ 135 $ 141

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The change in carrying amount of goodwill for the nine months ended September 30, 2023 was as follows (in millions): Goodwill as of December 31, 2022 $ 398 Effects of foreign currency translation — Goodwill as of September 30, 2023 $ 398 Intangible assets consisted of the following (in millions, except years): As of September 30, 2023 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 1.4 $ 2 $ (2) $ — Completed technology 5.0 71 (21) 50 Trade names 1.4 2 (1) 1 $ 75 $ (24) $ 51 As of December 31, 2022 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 2.1 $ 2 $ (1) $ 1 Completed technology 5.6 82 (23) 59 Trade names 2.1 2 (1) 1 $ 86 $ (25) $ 61 The following table presents our estimates of remaining amortization expense for finite-lived intangible assets at September 30, 2023 (in millions): Remainder of 2023 $ 3 2024 12 2025 10 2026 9 2027 8 Thereafter 9 Total amortization expense $ 51

Workforce Management

Workforce Management	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Workforce Management	Workforce Management During the nine months ended September 30, 2023, we substantially completed a workforce reduction plan, or the Workforce Reduction Plan, intended to reduce operating costs, improve operating margins, and continue advancing our ongoing commitment to profitable growth, primarily impacting our sales and marketing organization. In connection with the Workforce Reduction Plan, during the nine months ended September 30, 2023, we incurred $17 million in charges related to the statutory notice period and severance payments, employee benefits, and job placement services. (in millions) Workforce Reduction Plan Liability as of December 31, 2022 $ — Charges 17 Payments (16) Liability as of September 30, 2023 $ 1 The liability as of September 30, 2023 for charges in connection with the Workforce Reduction Plan is included in accrued payroll and payroll related liabilities in the condensed consolidated balance sheets. Charges related to the Workforce Reduction Plan are included in the condensed consolidated statements of operations and comprehensive loss, as follows (in millions): Three Months Ended September 30, 2023 Nine Months Ended September 30, 2023 Cost of goods sold $ — $ 1 Research and development 1 3 Sales and marketing 4 11 General and administrative — 2 Total $ 5 $ 17

Debt

Debt	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt Our debt consisted of the following, which comprises the current portion of certain convertible notes, our long-term convertible notes, and our long-term senior unsecured notes, each as further described below (in millions): As of September 30, 2023 As of December 31, 2022 2024 Notes 2026 Notes 2028 Notes 2023 Notes 2024 Notes 2026 Notes Liability: Principal $ 400 $ 400 $ 450 $ 85 $ 400 $ 400 Less: debt discount and issuance costs, net of amortization (1) (3) (9) — (3) (4) Net carrying amount $ 399 $ 397 $ 441 $ 85 $ 397 $ 396 Senior Unsecured Notes In March 2023, we sold $450 million aggregate principal amount of our 8.75% senior notes due 2028, or the 2028 Notes, in a private offering to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act of 1933, as amended, or the Securities Act, and outside the United States pursuant to Regulation S under the Securities Act. The 2028 Notes have not been registered, and we do not intend to register the 2028 Notes, under the Securities Act or the securities laws of any other jurisdiction. The 2028 Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of our subsidiaries. Interest on the 2028 Notes is payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2023. Unless earlier redeemed or repurchased, the 2028 Notes will mature on March 15, 2028. The effective interest rate of the 2028 Notes is 9.27%. The Indenture governing the 2028 Notes gives us the option to redeem some or all of the 2028 Notes at the redemption prices set forth in the Indenture, together with accrued and unpaid interest, if any, to, but excluding, the date of redemption. We may make optional redemptions at prices equal to 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus applicable “make-whole” premiums. In addition, we may redeem up to 40% of the original aggregate principal amount of the 2028 Notes using the net cash proceeds of certain equity offerings completed on or before March 15, 2025 at a redemption price of 108.75%. The 2028 Notes rank equal in right of payment to all of our and the guarantors’ existing and future senior indebtedness, including our 2024 Notes and 2026 Notes, each as defined below, and do not contain financial covenants but include covenants that, among other things, limit our ability to grant liens on certain assets to secure debt, grant a subsidiary guarantee of certain debt without also providing a guarantee of the 2028 Notes, and consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of our assets to, another person. Convertible Senior Notes The following table presents details of our convertible senior notes outstanding as of September 30, 2023, which are further discussed below (original principal in millions): Month Issued Maturity Date Original Principal (including over-allotment) Coupon Interest Rate Effective Interest Rate Conversion Rate Initial Conversion Price 2024 Notes August 2019 August 1, 2024 $ 400 0.5 % 0.93 % $ 5.2809 $ 189.36 2026 Notes August 2019 August 1, 2026 $ 400 1.0 % 1.32 % $ 5.2809 $ 189.36 As further defined and described below, the 2024 Notes and the 2026 Notes are together referred to as the 2024 & 2026 Notes, the 2023 Notes (as defined below) and the 2024 & 2026 Notes are collectively referred to as the Convertible Notes, and the 2023 Notes, 2024 & 2026 Notes, and 2028 Notes are collectively referred to as the Notes. Our 0.5% convertible senior notes due 2023, or the 2023 Notes, were settled on their maturity date of June 1, 2023. Cash paid for the settlement of the principal amount and the accrued interest of the 2023 Notes and settlement of a conversion request initiated in 2022 was $85 million. There were no other conversion requests for the 2023 Notes prior to the close of business on the second scheduled trading day immediately preceding the maturity date. The capped call transactions related to the 2023 Notes expired upon maturity of the 2023 Notes. The 2024 & 2026 Notes are our senior, unsecured obligations and interest is payable semi-annually in arrears on February 1 and August 1 of each year beginning February 1, 2020. Prior to the close of business on the business day immediately preceding May 1, 2024, or the 2024 Conversion Date, in the case of the 2024 Notes, or May 1, 2026, or the 2026 Conversion Date, in the case of the 2026 Notes, the respective Convertible Notes are convertible at the option of holders only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the relevant maturity date. The applicable conversion rate is subject to customary adjustments for certain events as described in the applicable indenture between us and U.S. Bank National Association, as trustee, or, collectively, the Indentures. Upon conversion, the Convertible Notes may be settled in shares of our Class A common stock, cash, or a combination of cash and shares of our Class A common stock, at our election. Prior to the close of business on the business day immediately preceding the applicable Conversion Date, the applicable series of Convertible Notes is convertible at the option of the holders under the following circumstances: • during any calendar quarter commencing after the calendar quarter subsequent to the calendar quarter in which the applicable series of Convertible Notes was issued (and only during such calendar quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the applicable series of Convertible Notes on each applicable trading day; • during the five-business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the applicable series of Convertible Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the applicable series of Convertible Notes on such applicable trading day; or • upon the occurrence of specified corporate events described in the applicable Indenture. As of September 30, 2023, the 2024 & 2026 Notes were not convertible. Because the 2024 Notes will mature on August 1, 2024, they have been classified as current liabilities in our condensed consolidated balance sheets as of September 30, 2023. We may not redeem any series of Convertible Notes prior to the relevant maturity date. Holders of any series of Convertible Notes have the right to require us to repurchase for cash all or a portion of their applicable series of Convertible Notes, at 100% of its respective principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change as defined in the applicable Indenture for such series of Convertible Notes. We are also required to increase the conversion rate for holders who convert their Convertible Notes in connection with certain corporate events occurring prior to the relevant maturity date. The Convertible Notes are our senior unsecured obligations and rank (i) senior in right of payment to any of our indebtedness and other liabilities that are expressly subordinated in right of payment to the Convertible Notes, (ii) equal in right of payment among all series of Convertible Notes, to the 2028 Notes, and to any other existing and future indebtedness and other liabilities that are not subordinated, (iii) effectively junior in right of payment to any of our secured indebtedness and other liabilities to the extent of the value of the assets securing such indebtedness and other liabilities, and (iv) structurally subordinated to all existing and future indebtedness (including the guarantees of the 2028 Notes by certain of our subsidiaries) and other liabilities (including trade payables) of our current or future subsidiaries. Capped Call Transactions In connection with the pricing of the 2024 & 2026 Notes, we entered into privately negotiated capped call transactions with other financial institutions. The capped call transactions are expected generally to reduce or offset potential dilution to holders of our common stock and/or offset the potential cash payments that we could be required to make in excess of the principal amount upon any conversion of the applicable series of Convertible Notes under certain circumstances, with such reduction and/or offset subject to a cap based on the cap price. Under the capped call transactions, we purchased capped call options that in the aggregate relate to the total number of shares of our Class A common stock underlying the applicable series of Convertible Notes, with an initial strike price of approximately $189.36 per share, which corresponds to the initial conversion price of each of the 2024 & 2026 Notes. Further, the capped call options are subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the applicable series of Convertible Notes, and have a cap price of $315.60 per share. Contractual Obligations of Notes The following table sets forth future contractual obligations of contractual interest and principal related to the Notes (in millions): Payments Due by Period Remainder of 2023 $ — 2024 445 2025 44 2026 443 2027 39 2028 470 Total principal and related contractual interest $ 1,441 The following tabl e sets forth interest expense recognized related to the Notes (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 11 $ 2 $ 27 $ 5 Amortization of debt issuance costs and discount 1 — 3 2 Total $ 12 $ 2 $ 30 $ 7

Equity Awards

Equity Awards	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Equity Awards	Equity Awards Stock Options Stock option activity, excluding activity related to the employee stock purchase plan, during the nine months ended September 30, 2023 consisted of the following (in thousands, except weighted-average information): Options Weighted- Options outstanding at December 31, 2022 1,106 $ 41.43 Granted — — Exercised (59) 4.69 Canceled/forfeited (5) 9.15 Options outstanding at September 30, 2023 1,042 $ 43.63 There were no options granted during the nine months ended September 30, 2023. As of September 30, 2023, there was $1 million of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 0.6 years. Restricted Stock Units Restricted stock unit, or RSU, and performance-based RSU, or PRSU, activity during the nine months ended September 30, 2023 consisted of the following (in thousands, except weighted-average information): Awards Outstanding (1) Weighted- Average Grant Date Fair Value (1) RSUs outstanding at December 31, 2022 9,928 $ 55.70 Granted 3,030 61.94 Vested (2,826) 66.63 Canceled/forfeited (1,518) 63.58 RSUs outstanding at September 30, 2023 8,614 $ 52.92 (1) Includes restricted stock units with market, performance, and/or service conditions. In March 2023, we granted PRSUs to certain executives with a grant date fair value of $14 million. These PRSUs are subject to vesting based on performance and service conditions and, assuming such conditions are met, will vest quarterly beginning in 2024 based upon the percentage achievement of certain annualized recurring revenue and operating margin metrics or will otherwise be forfeited on December 31, 2023 if the targets are not met. As of September 30, 2023, total unrecognized compensation expense related to unvested RSUs and PRSUs was approximately $343 million, which is expected to be recognized over a weighted-average period of 1.8 years. We classified stock-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive loss as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 5 $ 5 $ 13 $ 13 Research and development 15 14 43 40 Sales and marketing 22 22 69 56 General and administrative 20 20 58 55 Total $ 62 $ 61 $ 183 $ 164

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnification In the ordinary course of business, we enter into agreements in which we may agree to indemnify other parties with respect to certain matters, including losses resulting from claims of intellectual property infringement, damages to property or persons, business losses, or other liabilities. In addition, we have entered into indemnification agreements with our directors, executive officers, and certain other employees that will require us to indemnify them against liabilities that may arise by reason of their status or service as directors, officers, or employees. The terms of these indemnification agreements with our directors, executive officers, and other employees are generally perpetual after execution of the agreement. The maximum potential amount of future payments we could be required to make under certain of these indemnification provisions is unlimited; however, we maintain insurance that reduces our exposure and enables us to recover a portion of any future amounts paid. As of September 30, 2023 and December 31, 2022, we have not accrued a liability for indemnification provisions we agree to in the ordinary course of business or with our directors, executive officers, and certain other employees pursuant to indemnification agreements because the likelihood of incurring a payment obligation, if any, in connection with these arrangements is not probable or reasonably estimable. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. We are not currently party to any material legal proceedings or claims, nor are we aware of any pending or threatened legal proceedings or claims that could have a material adverse effect on our business, operating results, cash flows, or financial condition should such legal proceedings or claims be resolved unfavorably.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents details of the provision for income taxes and our effective tax rates (in millions, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Provision for income taxes $ 2 $ 1 $ 7 $ 4 Effective tax rate (4.2) % (1.6) % (2.8) % (1.5) % We account for income taxes according to ASC 740, which, among other things, requires that we estimate our annual effective income tax rate for the full year and apply it to pre-tax income (loss) for each interim period, taking into account year-to-date amounts and projected results for the full year. We periodically evaluate whether we will recover a portion or all of our deferred tax assets. We record a valuation allowance against our deferred tax assets if and to the extent it is more likely than not that we will not recover our deferred tax assets. In evaluating the need for a valuation allowance, we weight all relevant positive and negative evidence, including among other factors, historical financial performance, forecasts of income over the applicable carryforward periods, and our market environment, with each piece weighted based on its reliability. As of September 30, 2023, we had insufficient objective positive evidence that we will generate sufficient future pre-tax income to overcome the negative evidence of cumulative losses. Accordingly, we continue to record a full valuation allowance against our net U.S. and U.K. deferred tax assets as of September 30, 2023. We account for the tax effects of discrete events in the interim period they occur. The provision for income taxes consists of federal, foreign, state, and local income taxes. Our effective tax rate differs from the statutory U.S. income tax rate due to the effect of state and local income taxes, differing tax rates imposed on income earned in foreign jurisdictions and in the United States, losses in foreign jurisdictions, certain nondeductible expenses, excess tax deductions, and the changes in valuation allowances against our deferred tax assets. Our effective tax rate could change significantly from quarter to quarter because of recurring and nonrecurring factors. The provision for income taxes for each of the three and nine months ended September 30, 2022 and 2023 was primarily attributable to increased foreign withholding tax and state minimum tax in the related jurisdictions. In addition, there was an increase in foreign income taxes due to profitability in certain foreign subsidiaries. We did not recognize benefits from excess tax deductions from exercised stock options and settled RSUs or net operating losses for either the three and nine months ended September 30, 2022 or 2023 as a result of the full valuation allowance against our U.S. and U.K. net deferred tax assets. Neither we nor any of our subsidiaries are currently under examination from tax authorities in the jurisdictions in which we do business.

Basic and Diluted Net Loss Per

Basic and Diluted Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Basic and Diluted Net Loss Per Share	Basic and Diluted Net Loss Per Share The following table presents the computation of net loss per share (in millions, except shares in thousands and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss attributable to common stockholders $ (50) $ (75) $ (259) $ (287) Denominator: Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted 71,305 68,673 70,615 68,273 Net loss per share attributable to common stockholders, basic and diluted $ (0.70) $ (1.09) $ (3.67) $ (4.20) Since we were in a loss position for all periods presented, basic net loss is the same as diluted net loss per share for all periods as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average equivalent shares of common stock were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Stock awards 7,424 8,790 8,096 8,186 Convertible senior notes 4,225 6,136 4,684 6,136 Total shares excluded from net loss per share 11,649 14,926 12,780 14,322

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (50)	$ (120)	$ (89)	$ (75)	$ (107)	$ (105)	$ (259)	$ (287)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Alteryx, Inc. and its subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim periods. Certain information and disclosures normally included in consolidated financial statements presented in accordance with U.S. GAAP have been condensed or omitted. Certain reclassifications have been made to the fiscal year 2022 condensed consolidated financial statements to conform to the fiscal year 2023 presentation. The reclassifications had no impact on comprehensive loss, total assets, total liabilities, or stockholders’ equity. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, or the Annual Report, filed with the Securities and Exchange Commission, or SEC, on February 10, 2023. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments that are necessary to state fairly the financial position, results of operations, comprehensive loss, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending December 31, 2023. During the three months ended June 30, 2023, management elected to change the presentation of our financial statements and accompanying footnote disclosures from thousands to millions. The change in presentation had no material impact on previously reported financial information, but certain amounts reported for prior periods may differ by insignificant amounts due to the nature of rounding relative to the change in presentation. In addition, historical percentages and per share amounts presented may not add to their respective totals or recalculate due to rounding.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, income tax valuations, stock-based compensation, and goodwill and intangible assets valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities.
Recent Accounting Pronouncements	Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements, or recently adopted accounting guidance during the nine months ended September 30, 2023 that are of significance or potential significance to us.
Income Taxes	We account for income taxes according to ASC 740, which, among other things, requires that we estimate our annual effective income tax rate for the full year and apply it to pre-tax income (loss) for each interim period, taking into account year-to-date amounts and projected results for the full year. We periodically evaluate whether we will recover a portion or all of our deferred tax assets. We record a valuation allowance against our deferred tax assets if and to the extent it is more likely than not that we will not recover our deferred tax assets. In evaluating the need for a valuation allowance, we weight all relevant positive and negative evidence, including among other factors, historical financial performance, forecasts of income over the applicable carryforward periods, and our market environment, with each piece weighted based on its reliability. As of September 30, 2023, we had insufficient objective positive evidence that we will generate sufficient future pre-tax income to overcome the negative evidence of cumulative losses. Accordingly, we continue to record a full valuation allowance against our net U.S. and U.K. deferred tax assets as of September 30, 2023.We account for the tax effects of discrete events in the interim period they occur. The provision for income taxes consists of federal, foreign, state, and local income taxes. Our effective tax rate differs from the statutory U.S. income tax rate due to the effect of state and local income taxes, differing tax rates imposed on income earned in foreign jurisdictions and in the United States, losses in foreign jurisdictions, certain nondeductible expenses, excess tax deductions, and the changes in valuation allowances against our deferred tax assets. Our effective tax rate could change significantly from quarter to quarter because of recurring and nonrecurring factors.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The disaggregation of revenue by region was as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by region: United States $ 169 $ 141 $ 441 $ 381 International 63 74 178 173 Total $ 232 $ 215 $ 619 $ 554
Deferred Contract Costs	A summary of the activity impacting our deferred commissions during the three and nine months ended September 30, 2023 and 2022 is presented below (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Beginning balance (1) $ 103 $ 71 $ 96 $ 70 Additional deferred commissions 25 25 73 58 Amortization of deferred commissions (21) (19) (63) (49) Effects of foreign currency translation (1) (1) — (3) Ending balance $ 106 $ 76 $ 106 $ 76 (1) Of the total amount of commissions deferred as of January 1, 2023 and January 1, 2022, $2 million and $6 million were paid in shares of our Class A common stock in the nine months ended September 30, 2023 and September 30, 2022, respectively. No payments were made in shares in the three months ended September 30, 2023 and September 30, 2022.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Summary of Cash and Cash Equivalents and Investments' Costs, Gross Unrealized Gains (Losses), and Fair Value by Major Security Type Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Investments	The following tables present our cash and cash equivalents’ and investments’ costs, net unrealized gains (losses), and fair value by major security type recorded as cash and cash equivalents or short-term or long-term investments as of September 30, 2023 and December 31, 2022 (in millions): As of September 30, 2023 Cost Net Fair Value Cash and Short-term Long-term Cash $ 43 $ — $ 43 $ 43 $ — $ — Level 1: Money market funds 406 — 406 406 — — Subtotal 406 — 406 406 — — Level 2: Commercial paper 28 — 28 14 14 — Certificates of deposit 6 — 6 — 6 — U.S. Treasury and agency bonds 186 (1) 185 — 140 45 Corporate bonds 14 — 14 — 12 2 Subtotal 234 (1) 233 14 172 47 Level 3: — — — — — — Total $ 683 $ (1) $ 682 $ 463 $ 172 $ 47 As of December 31, 2022 Cost Net Fair Value Cash and Short-term Long-term Cash $ 63 $ — $ 63 $ 63 $ — $ — Level 1: Money market funds 20 — 20 20 — — Subtotal 20 — 20 20 — — Level 2: Commercial paper 60 — 60 21 39 — Certificates of deposit 6 — 6 — 6 — U.S. Treasury and agency bonds 237 (3) 234 1 156 77 Corporate bonds 46 (1) 45 — 36 9 Subtotal 349 (4) 345 22 237 86 Level 3: — — — — — — Total $ 432 $ (4) $ 428 $ 105 $ 237 $ 86

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Prepaid expenses and other current assets consisted of the following (in millions): September 30, 2023 December 31, 2022 Contract asset $ 79 $ 60 Deferred commissions 46 41 Prepaid expenses 28 38 Other 9 6 Total $ 162 $ 145
Schedule of Other Assets	Other assets consisted of the following (in millions): September 30, 2023 December 31, 2022 Contract asset $ 56 $ 71 Deferred commissions 60 55 Other 19 15 Total $ 135 $ 141

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Change in Carrying Amount of Goodwill	The change in carrying amount of goodwill for the nine months ended September 30, 2023 was as follows (in millions): Goodwill as of December 31, 2022 $ 398 Effects of foreign currency translation — Goodwill as of September 30, 2023 $ 398
Schedule of Intangible Assets	Intangible assets consisted of the following (in millions, except years): As of September 30, 2023 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 1.4 $ 2 $ (2) $ — Completed technology 5.0 71 (21) 50 Trade names 1.4 2 (1) 1 $ 75 $ (24) $ 51 As of December 31, 2022 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 2.1 $ 2 $ (1) $ 1 Completed technology 5.6 82 (23) 59 Trade names 2.1 2 (1) 1 $ 86 $ (25) $ 61
Schedule of Finite-Lived Intangible Assets Estimated Remaining Amortization Expense	The following table presents our estimates of remaining amortization expense for finite-lived intangible assets at September 30, 2023 (in millions): Remainder of 2023 $ 3 2024 12 2025 10 2026 9 2027 8 Thereafter 9 Total amortization expense $ 51

Workforce Management (Tables)

Workforce Management (Tables)	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	In connection with the Workforce Reduction Plan, during the nine months ended September 30, 2023, we incurred $17 million in charges related to the statutory notice period and severance payments, employee benefits, and job placement services. (in millions) Workforce Reduction Plan Liability as of December 31, 2022 $ — Charges 17 Payments (16) Liability as of September 30, 2023 $ 1 Charges related to the Workforce Reduction Plan are included in the condensed consolidated statements of operations and comprehensive loss, as follows (in millions): Three Months Ended September 30, 2023 Nine Months Ended September 30, 2023 Cost of goods sold $ — $ 1 Research and development 1 3 Sales and marketing 4 11 General and administrative — 2 Total $ 5 $ 17

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	Our debt consisted of the following, which comprises the current portion of certain convertible notes, our long-term convertible notes, and our long-term senior unsecured notes, each as further described below (in millions): As of September 30, 2023 As of December 31, 2022 2024 Notes 2026 Notes 2028 Notes 2023 Notes 2024 Notes 2026 Notes Liability: Principal $ 400 $ 400 $ 450 $ 85 $ 400 $ 400 Less: debt discount and issuance costs, net of amortization (1) (3) (9) — (3) (4) Net carrying amount $ 399 $ 397 $ 441 $ 85 $ 397 $ 396
Summary of Convertible Debt	The following table presents details of our convertible senior notes outstanding as of September 30, 2023, which are further discussed below (original principal in millions): Month Issued Maturity Date Original Principal (including over-allotment) Coupon Interest Rate Effective Interest Rate Conversion Rate Initial Conversion Price 2024 Notes August 2019 August 1, 2024 $ 400 0.5 % 0.93 % $ 5.2809 $ 189.36 2026 Notes August 2019 August 1, 2026 $ 400 1.0 % 1.32 % $ 5.2809 $ 189.36
Contractual Obligation, Fiscal Year Maturity	The following table sets forth future contractual obligations of contractual interest and principal related to the Notes (in millions): Payments Due by Period Remainder of 2023 $ — 2024 445 2025 44 2026 443 2027 39 2028 470 Total principal and related contractual interest $ 1,441
Summary of Interest Expense	The following tabl e sets forth interest expense recognized related to the Notes (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 11 $ 2 $ 27 $ 5 Amortization of debt issuance costs and discount 1 — 3 2 Total $ 12 $ 2 $ 30 $ 7

Equity Awards (Tables)

Equity Awards (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity, excluding activity related to the employee stock purchase plan, during the nine months ended September 30, 2023 consisted of the following (in thousands, except weighted-average information): Options Weighted- Options outstanding at December 31, 2022 1,106 $ 41.43 Granted — — Exercised (59) 4.69 Canceled/forfeited (5) 9.15 Options outstanding at September 30, 2023 1,042 $ 43.63
Schedule of RSU Activity	Restricted stock unit, or RSU, and performance-based RSU, or PRSU, activity during the nine months ended September 30, 2023 consisted of the following (in thousands, except weighted-average information): Awards Outstanding (1) Weighted- Average Grant Date Fair Value (1) RSUs outstanding at December 31, 2022 9,928 $ 55.70 Granted 3,030 61.94 Vested (2,826) 66.63 Canceled/forfeited (1,518) 63.58 RSUs outstanding at September 30, 2023 8,614 $ 52.92 (1) Includes restricted stock units with market, performance, and/or service conditions.
Schedule of Stock-based Compensation Expense	We classified stock-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive loss as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 5 $ 5 $ 13 $ 13 Research and development 15 14 43 40 Sales and marketing 22 22 69 56 General and administrative 20 20 58 55 Total $ 62 $ 61 $ 183 $ 164

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes and Effective Tax Rates	The following table presents details of the provision for income taxes and our effective tax rates (in millions, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Provision for income taxes $ 2 $ 1 $ 7 $ 4 Effective tax rate (4.2) % (1.6) % (2.8) % (1.5) %

Basic and Diluted Net Loss Pe_2

Basic and Diluted Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Net Income Per Share	The following table presents the computation of net loss per share (in millions, except shares in thousands and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss attributable to common stockholders $ (50) $ (75) $ (259) $ (287) Denominator: Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted 71,305 68,673 70,615 68,273 Net loss per share attributable to common stockholders, basic and diluted $ (0.70) $ (1.09) $ (3.67) $ (4.20)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following weighted-average equivalent shares of common stock were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Stock awards 7,424 8,790 8,096 8,186 Convertible senior notes 4,225 6,136 4,684 6,136 Total shares excluded from net loss per share 11,649 14,926 12,780 14,322

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 232	$ 215	$ 619	$ 554
United States
Disaggregation of Revenue [Line Items]
Total revenue	169	141	441	381
International
Disaggregation of Revenue [Line Items]
Total revenue	$ 63	$ 74	$ 178	$ 173
United Kingdom | Revenue from contract with customer | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		10.60%
Canada | Revenue from contract with customer | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		11.30%

Revenue - Contract Assets and C

Revenue - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Contract with customer, liability, current	$ 179		$ 179		$ 276
Revenue recognized related to amounts that were included in deferred revenue	94	$ 91	233	$ 180
Contract with Customer, Liability, Current
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Contract with customer, liability, current	179		179		276
Other Noncurrent Liabilities
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Deferred revenue	$ 4		$ 4		$ 4

Revenue - Assets Recognized fro

Revenue - Assets Recognized from Costs to Obtain Contracts with Customers (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jan. 01, 2023	Jan. 01, 2022
Change in Capitalized Contract Costs [Roll Forward]
Beginning balance	$ 103,000,000	$ 71,000,000	$ 96,000,000	$ 70,000,000
Additional deferred commissions	25,000,000	25,000,000	73,000,000	58,000,000
Amortization of deferred commissions	(21,000,000)	(19,000,000)	(63,000,000)	(49,000,000)
Effects of foreign currency translation	(1,000,000)	(1,000,000)	0	(3,000,000)
Ending balance	106,000,000	76,000,000	106,000,000	76,000,000
Capitalized contract cost, net	106,000,000	76,000,000	106,000,000	76,000,000
Capitalized contract cost, net, current	46,000,000	33,000,000	46,000,000	33,000,000
Impairments of assets related to deferred contract costs	0	0	0	0
Capitalized contract cost	$ 0	$ 0	$ 0	$ 0
Class A common stock
Change in Capitalized Contract Costs [Roll Forward]
Capitalized contract cost, net					$ 2,000,000	$ 6,000,000

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) $ in Millions	Sep. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 517
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 483
Remaining performance obligation, period	24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, period

Business Combinations - Additio

Business Combinations - Additional Information (Detail) - USD ($) $ in Millions		5 Months Ended	9 Months Ended
	Feb. 07, 2022	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 398	$ 398
Trifacta Inc.
Business Acquisition [Line Items]
Business combination acquired percentage	100%
Cash paid to acquire business	$ 398
Goodwill	341
Trifacta Inc. | General and administrative
Business Acquisition [Line Items]
Acquisition related costs		$ 11	$ 8
Trifacta Inc. | Completed technology
Business Acquisition [Line Items]
Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles	$ 49
Trifacta Inc. | Completed technology | Level 3 | Measurement Input, Discount Rate
Business Acquisition [Line Items]
Business combination, measurement input, discount rate	0.165

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Cash and Cash Equivalents and Investments' Costs, Gross Unrealized Gains (Losses), and Fair Value by Major Security Type Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Investments (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	$ 463	$ 105
Investments, fair value	219
Short-term Investments	172	237
Long-term Investments	47	90
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	463	105
Net Unrealized Gains (Losses)	(1)	(4)
Cash and cash equivalents and investment, cost	683	432
Cash and cash equivalents and investments, fair value	682	428
Short-term Investments	172	237
Long-term Investments	47	86
Fair Value, Measurements, Recurring | Cash
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	43	63
Cash and cash equivalents, fair value	43	63
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	406	20
Cash and cash equivalents, fair value	406	20
Fair Value, Measurements, Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	406	20
Cash and cash equivalents, fair value	406	20
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	14	22
Investments, cost	234	349
Net Unrealized Gains (Losses)	(1)	(4)
Investments, fair value	233	345
Short-term Investments	172	237
Long-term Investments	47	86
Fair Value, Measurements, Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	14	21
Investments, cost	28	60
Net Unrealized Gains (Losses)	0	0
Investments, fair value	28	60
Short-term Investments	14	39
Long-term Investments	0	0
Fair Value, Measurements, Recurring | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	6	6
Net Unrealized Gains (Losses)	0	0
Investments, fair value	6	6
Short-term Investments	6	6
Long-term Investments	0	0
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury and agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	1
Investments, cost	186	237
Net Unrealized Gains (Losses)	(1)	(3)
Investments, fair value	185	234
Short-term Investments	140	156
Long-term Investments	45	77
Fair Value, Measurements, Recurring | Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	14	46
Net Unrealized Gains (Losses)	0	(1)
Investments, fair value	14	45
Short-term Investments	12	36
Long-term Investments	2	9
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	0	0
Net Unrealized Gains (Losses)	0	0
Investments, fair value	0	0
Short-term Investments	0	0
Long-term Investments	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Fair Value Disclosures [Line Items]
Gross unrealized losses	$ 1,000,000
Investments, fair value	219,000,000
Other investments	12,000,000	$ 4,000,000
Other investments, impairment	0
2024 Notes | Fair Value, Nonrecurring | Level 2
Fair Value Disclosures [Line Items]
Fair value of notes	384,000,000	105,000,000
2026 Notes | Fair Value, Nonrecurring | Level 2
Fair Value Disclosures [Line Items]
Fair value of notes	359,000,000	369,000,000
2028 Notes | Fair Value, Nonrecurring | Level 2
Fair Value Disclosures [Line Items]
Fair value of notes	$ 449,000,000	$ 332,000,000
Minimum
Fair Value Disclosures [Line Items]
Long-term investments maturity period	1 year
Maximum
Fair Value Disclosures [Line Items]
Long-term investments maturity period	2 years

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Contract asset	$ 79	$ 60
Deferred commissions	46	41
Prepaid expenses	28	38
Other	9	6
Prepaid expenses and other current assets	$ 162	$ 145

Balance Sheet Components - Othe

Balance Sheet Components - Other Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Contract asset	$ 56	$ 71
Deferred commissions	60	55
Other	19	15
Total	$ 135	$ 141

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Change in Carrying Amount of Goodwill (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill as of December 31, 2022	$ 398
Effects of foreign currency translation	0
Goodwill as of September 30, 2023	$ 398

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 75	$ 86
Accumulated Amortization	(24)	(25)
Net Carrying Value	$ 51	$ 61
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	1 year 4 months 24 days	2 years 1 month 6 days
Gross Carrying Value	$ 2	$ 2
Accumulated Amortization	(2)	(1)
Net Carrying Value	$ 0	$ 1
Completed technology
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	5 years	5 years 7 months 6 days
Gross Carrying Value	$ 71	$ 82
Accumulated Amortization	(21)	(23)
Net Carrying Value	$ 50	$ 59
Trade names
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	1 year 4 months 24 days	2 years 1 month 6 days
Gross Carrying Value	$ 2	$ 2
Accumulated Amortization	(1)	(1)
Net Carrying Value	$ 1	$ 1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets Estimated Remaining Amortization Expense (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 3
2024	12
2025	10
2026	9
2027	8
Thereafter	9
Net Carrying Value	$ 51	$ 61

Workforce Management - Narrativ

Workforce Management - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring costs	$ 5	$ 17

Workforce Management - Restruct

Workforce Management - Restructuring Reserve (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		$ 0
Charges	$ 5	17
Payments		(16)
Restructuring reserve, ending balance	$ 1	$ 1

Workforce Management - Restru_2

Workforce Management - Restructuring Charges (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 5	$ 17
Cost of revenue
Restructuring Cost and Reserve [Line Items]
Restructuring costs	0	1
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1	3
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring costs	4	11
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 0	$ 2

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Aug. 31, 2019
Debt Instrument [Line Items]
Net carrying amount	$ 838		$ 793
2023 Notes | Convertible senior notes
Debt Instrument [Line Items]
Principal			85
Less: debt discount and issuance costs, net of amortization			0
Net carrying amount			85
2024 Notes | Convertible senior notes
Debt Instrument [Line Items]
Principal	400		400	$ 400
Less: debt discount and issuance costs, net of amortization	(1)		(3)
Net carrying amount	399		397
2026 Notes | Convertible senior notes
Debt Instrument [Line Items]
Principal	400		400	$ 400
Less: debt discount and issuance costs, net of amortization	(3)		(4)
Net carrying amount	397		$ 396
2028 Notes | Senior Notes
Debt Instrument [Line Items]
Principal	450	$ 450
Less: debt discount and issuance costs, net of amortization	(9)
Net carrying amount	$ 441

Debt - Additional Information (

Debt - Additional Information (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($) d	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Aug. 31, 2019 USD ($) $ / option
Debt Instrument [Line Items]
Redemption price, percentage	100%
Price risk derivative
Debt Instrument [Line Items]
Capped calls, initial strike price (in dollars per share) | $ / option				189.36
Capped calls, cap price (in dollars per share) | $ / option				315.60
Senior Notes | 2028 Notes
Debt Instrument [Line Items]
Principal | $	$ 450	$ 450
Coupon Interest Rate		8.75%
Effective Interest Rate		9.27%
Senior Notes | 2028 Notes | Debt instrument, conversion, option one
Debt Instrument [Line Items]
Redemption price, percentage	100%
Senior Notes | 2028 Notes | Debt instrument, conversion, option two
Debt Instrument [Line Items]
Redemption price, percentage	108.75%
Debt instrument, redemption price, percentage of principal amount redeemed	40%
Convertible senior notes | 2023 Notes
Debt Instrument [Line Items]
Principal | $			$ 85
Repayments of debt | $	$ 85
Convertible senior notes | Convertible senior notes due 2023, 2024, 2026 | Debt instrument, conversion, option one
Debt Instrument [Line Items]
Convertible debt, threshold trading days | d	20
Convertible debt, threshold consecutive trading days | d	30
Convertible debt, threshold percentage of stock price trigger	130%
Convertible senior notes | Convertible senior notes due 2023, 2024, 2026 | Debt instrument, conversion, option two
Debt Instrument [Line Items]
Convertible debt, threshold trading days | d	5
Convertible debt, threshold consecutive trading days | d	5
Convertible debt, threshold percentage of stock price trigger	98%
Convertible senior notes | 2024 Notes
Debt Instrument [Line Items]
Principal | $	$ 400		$ 400	$ 400
Coupon Interest Rate				0.50%
Effective Interest Rate				0.93%

Debt - Summary of Debt (Details

Debt - Summary of Debt (Details) - Convertible senior notes $ / shares in Units, $ in Millions	1 Months Ended
	Aug. 31, 2019 USD ($) $ / shares	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
2024 Notes
Debt Instrument [Line Items]
Original Principal (including over-allotment) | $	$ 400	$ 400	$ 400
Coupon Interest Rate	0.50%
Effective Interest Rate	0.93%
Conversion Rate	0.0052809
Initial Conversion Price (in usd per share) | $ / shares	$ 189.36
2026 Notes
Debt Instrument [Line Items]
Original Principal (including over-allotment) | $	$ 400	$ 400	$ 400
Coupon Interest Rate	1%
Effective Interest Rate	1.32%
Conversion Rate	0.0052809
Initial Conversion Price (in usd per share) | $ / shares	$ 189.36

Debt - Schedule of Contractual

Debt - Schedule of Contractual Obligations and Contractual Interest (Details) $ in Millions	Sep. 30, 2023 USD ($)
Debt Disclosure [Abstract]
Remainder of 2023	$ 0
2024	445
2025	44
2026	443
2027	39
2028	470
Total principal and related contractual interest	$ 1,441

Debt - Summary of Interest Expe

Debt - Summary of Interest Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 11	$ 2	$ 27	$ 5
Amortization of debt discount and issuance costs	1	0	3	2
Total	$ 12	$ 2	$ 30	$ 7

Equity Awards - Schedule of Sto

Equity Awards - Schedule of Stock Option Activity (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Options Outstanding
Options outstanding, beginning balance (in shares) | shares	1,106
Granted (in shares) | shares	0
Exercised (in shares) | shares	(59)
Canceled/forfeited (in shares) | shares	(5)
Options outstanding, ending balance (in shares) | shares	1,042
Weighted- Average Exercise Price
Weighted-average exercise price, beginning balance (in dollars per share) | $ / shares	$ 41.43
Weighted-average exercise price, granted (in dollars per share) | $ / shares	0
Weighted-average exercise price, exercised (in dollars per share) | $ / shares	4.69
Weighted-average exercise price, canceled/forfeited (in dollars per share) | $ / shares	9.15
Weighted-average exercise price, ending balance (in dollars per share) | $ / shares	$ 43.63

Equity Awards - Additional Info

Equity Awards - Additional Information (Details) - USD ($) shares in Thousands, $ in Millions	9 Months Ended
	Sep. 30, 2023	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested stock options	$ 1
Weighted-average period, expected to be recognized	7 months 6 days
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average period, expected to be recognized	1 year 9 months 18 days
Aggregate grant date fair value		$ 14
Unrecognized compensation expense, related to unvested RSUs	$ 343

Equity Awards - Schedule of RSU

Equity Awards - Schedule of RSU Activity (Details) - Restricted stock units shares in Thousands	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Awards Outstanding
Beginning balance (in shares) | shares	9,928
Granted (in shares) | shares	3,030
Vested (in shares) | shares	(2,826)
Canceled/forfeited (in shares) | shares	(1,518)
Ending balance (in shares) | shares	8,614
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 55.70
Granted (in dollars per share) | $ / shares	61.94
Vested (in dollars per share) | $ / shares	66.63
Canceled/forfeited (in dollars per share) | $ / shares	63.58
Ending balance (in dollars per share) | $ / shares	$ 52.92

Equity Awards - Schedule of S_2

Equity Awards - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 62	$ 61	$ 183	$ 164
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	5	5	13	13
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	15	14	43	40
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	22	22	69	56
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 20	$ 20	$ 58	$ 55

Contingencies (Details)

Contingencies (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Indemnification
Commitments And Contingencies [Line Items]
Loss contingency accrual	$ 0	$ 0

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision for Income Taxes and Effective Tax Rates (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 2	$ 1	$ 7	$ 4
Effective tax rate	(4.20%)	(1.60%)	(2.80%)	(1.50%)

Basic and Diluted Net Loss Pe_3

Basic and Diluted Net Loss Per Share - Schedule of Computation of Net Loss per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss attributable to common stockholders	$ (50)	$ (75)	$ (259)	$ (287)
Denominator:
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares)	71,305	68,673	70,615	68,273
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares)	71,305	68,673	70,615	68,273
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.70)	$ (1.09)	$ (3.67)	$ (4.20)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.70)	$ (1.09)	$ (3.67)	$ (4.20)

Basic and Diluted Net Loss Pe_4

Basic and Diluted Net Loss Per Share - Weighted-average Equivalent Shares Excluded From Diluted Net Loss per Share Calculation (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	11,649	14,926	12,780	14,322
Stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	7,424	8,790	8,096	8,186
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	4,225	6,136	4,684	6,136

Uncategorized Items - ayx-20230

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]